Film coated pellets containing verapamil hydrochloride: enhanced dissolution into neutral medium.
Weakly basic drugs, such as verapamil hydrochloride, that are poorly soluble in neutral/alkaline medium may have poor oral bioavailability due to reduced solubility in the small intestine and colon. Film coated pellets were prepared using two strategies to enhance drug release at high pH values. Firstly, pellets were coated with Eudragit RS/hydroxypropyl methylcellulose acetate succinate (HMAS) mixtures in proportions of 10:1 and 10:3, respectively. The enteric polymer, HMAS, would dissolve in medium at pH > 6 creating pores through the insoluble Eudragit RS membrane to increase drug release. Secondly, an acidic environment was created within the core by the inclusion of fumaric acid at concentrations of 5 and 10% in order to increase drug solubility. Both strategies enhanced drug release into neutral medium in dissolution studies using the pH change method to simulate GIT transit. Dissolution profiles of samples tested in pH 1.2 for 12 hr were compared with those using the pH change method (pH 1.2 for first 1.5 hr, pH raised to 6.8 for remaining 10.5 hr) using the area under the dissolution curve (AUC), the dissolution half-life (t50%), and the amount of drug released in 3 hr (A3hr) values. Both strategies enhanced drug release into neutral medium although the strategy using HMAS in the film was more effective. The formulation least affected by pH change was a combination of the two strategies, i.e., pellets containing 5% fumaric acid coated with Eudragit RS 12% w/w and HMAS 1.2% w/w.
Munday
Dale L
DL
School of Pharmacy, The Robert Gordon University, Schoolhill, Aberdeen, UK. d.munday@rgu.ac.uk
D000180:Acrylic Resins / Q000737:chemistry; D004339:Drug Compounding; D004343:Drug Implants; D005079:Excipients / Q000737:chemistry; D005650:Fumarates / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008747:Methylcellulose / Q000031:analogs & derivatives* / Q000737:chemistry; D008855:Microscopy, Electron, Scanning; D012995:Solubility; D013499:Surface Properties; D013997:Time Factors; D014700:Verapamil / Q000737:chemistry*
D000180:Acrylic Resins; D004343:Drug Implants; D005079:Excipients; D005650:Fumarates; C050528:Eudragit RS; C048331:hydroxypropylmethylcellulose acetate succinate; C032005:fumaric acid; D008747:Methylcellulose; D014700:Verapamil